| Views | |
|---|---|
| Favorable therapeutic response after anti-Mesothelin antibody–drug conjugate treatment requires high expression of Mesothelin in tumor cells | 126 |
| January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | |
|---|---|---|---|---|---|---|---|
| Favorable therapeutic response after anti-Mesothelin antibody–drug conjugate treatment requires high expression of Mesothelin in tumor cells | 4 | 20 | 0 | 26 | 0 | 0 | 0 |
| Views | |
|---|---|
| 2020_Lazzerini_etal.pdf | 53 |
